Fonte: Rheumatology international. Unidade: FM
Assuntos: ESTATINAS, DISLIPIDEMIAS, MIOSITE
ABNT
BORGES, Isabela Bruna Pires e SHINJO, Samuel Katsuyuki. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatology international, v. 39, n. 2, p. 311-316, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00296-018-4215-x. Acesso em: 30 set. 2024.APA
Borges, I. B. P., & Shinjo, S. K. (2019). Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatology international, 39( 2), 311-316. doi:10.1007/s00296-018-4215-xNLM
Borges IBP, Shinjo SK. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies [Internet]. Rheumatology international. 2019 ; 39( 2): 311-316.[citado 2024 set. 30 ] Available from: https://doi.org/10.1007/s00296-018-4215-xVancouver
Borges IBP, Shinjo SK. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies [Internet]. Rheumatology international. 2019 ; 39( 2): 311-316.[citado 2024 set. 30 ] Available from: https://doi.org/10.1007/s00296-018-4215-x